multiplex diagnostics
Published on Monday, the work describes a foundational technology being commercialized by startup VedaBio.
FDA Clears Qiagen's Five-Target Syndromic GI Panel
The firm said it is the first to have both comprehensive and targeted qPCR panels to detect gastrointestinal pathogens.
Top Five Articles on 360Dx Last Week: QuidelOrtho's Plans; Sekisui's EUAs for COVID Tests; More
Last week, readers were most interested in an update by QuidelOrtho management on the direction of the firm.
NIH RADx Program Awards Autonomous Medical Devices Incorporated $5.2M in Phase 2 Funding
The award follows $1.2 million in 2023 and supports the final development of a rapid PCR-based system and a respiratory panel.
Seegene, Microsoft Collaborate to Support MDx Development
Seegene has selected Microsoft as a technology partner for its SG OneSystem business to enable the local development of syndromic qPCR tests.
Mar 17, 2022